A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

In April, midway through the Guinness Women’s Six Nations, Scotland women’s young gun Alex Stewart was diagnosed with ...

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

The upcoming Axiom-4 mission to the International Space Station (ISS), featuring Indian astronaut Shubhanshu Shukla, will ...

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

Patient satisfaction. More patients in the insulin pen group (77.1%) dialed at least one dose of insulin using the pen device, compared with 5% of patients who drew at least one dose using the ...

The authors found that diabetes-related and overall medication adherence were comparable for patients initiating insulin with a pen versus a vial and syringe (53% versus 50% and 94% versus 94% ...